Archive | Biotech RSS feed for this section

3 American-Based Businesses that Trump Loves

These three companies employ tens of thousands of Americans and will never be shipping jobs or factories overseas, giving them an A+ rating from Trump. With the President-elect’s support behind them, these stocks should do well. Trump has started fulfilling his campaign promise of ‘strong arming’ companies to stop moving jobs out of the country […]

Read more

3 Reasons Why this Biotech Rally is the Real Deal

After dropping some 20% in 2016, the biotech sector could be set for the rally of a lifetime in 2017 and make current investors a fortune in the process. See why Bret Jensen thinks this rally is for real in today’s article.  The biotech sector was one of the poorest performers in the market in […]

Read more

3 Stocks under $10 with Breakout Potential

After executing perfectly on their business plans in 2016, these three stocks look set to reap the profits in 2017. With buyout potential and higher share prices expected in the New Year, adding these three stocks to your portfolio today looks like a smart move.  It is hard to believe 2016 has already come and […]

Read more

The 3 Stocks that Will Go from Worst to First in 2017

Take advantage of the stock market phenomenon where the worst performers of the last 12 months tend to become the best performers in the next. Bret Jensen searched through the 25 biggest laggards in the S&P 500 and found three stocks to buy for share price gains.  The NFL regular season has now drawn to […]

Read more

3 Best Buy Healthcare Stocks Too Cheap by Half

Easily taking the prize of the worst performing sector in 2016, healthcare stocks look set to turnaround in 2017 with a more pro-industry administration in office. With that in mind, check out these three growth stocks on sale today.  From political outlash to Hillary Clinton’s tweet storms on drug pricing, the healthcare industry has had […]

Read more

3 Stocks to Buy on the Verge of Breakout Gains

With positive news flowing in, you should ring in the New Year with these three companies that could soon see breakout gains. After expertly working through some bad news this year, all three stocks look set to go from worst to first in 2017.  2016 is quickly coming to a close, and the year was […]

Read more

3 Biotech Stocks to Buy Before the Massive Sector Rally

Jumping up 8% after the election of Donald Trump, the biotech sector can still gain 20% more before it reaches back to its 52-week high. Don’t miss out on what could be the biggest rally the market sees in 2017. Here are three stocks that could lead the way. Christmas came early for biotech investors […]

Read more

The 2 Stocks Cashing in on a Cure for This Rare Disease

Treating a rare disease that affects 15,000 people in the U.S. could mean upwards of $400 million in sales a year just in the States but also $1 billion in sales worldwide. To invest in this trend, consider the two front-runner comapnies profiled today. The Profitable Niche of Treating Rare Diseases Investors in the biotech […]

Read more

3 Stocks That are Ripe for a Takeover

By investing in these three mid-cap stocks with emerging growth stories you can greatly increase your chance of owning a stock that gets taken out by a larger player. Especially since their sector is flush with big companies holding loads of cash and looking to buy growth. Biotech had its best weekly performance in more […]

Read more

3 Biotech Stocks Set to Soar Under Republican Leadership

After being the market’s whipping boy for the last year, the biotech sector looks ready to rebound under a pro-business White House. Already, many stocks have shot up over 50%, but Bret Jensen shares three today that still have plenty of upside backed up by strong products already on the market.  The biotech sector has […]

Read more